1. Home
  2. LAC vs RAPP Comparison

LAC vs RAPP Comparison

Compare LAC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAC
  • RAPP
  • Stock Information
  • Founded
  • LAC 2023
  • RAPP 2022
  • Country
  • LAC Canada
  • RAPP United States
  • Employees
  • LAC N/A
  • RAPP N/A
  • Industry
  • LAC Metal Mining
  • RAPP
  • Sector
  • LAC Basic Materials
  • RAPP
  • Exchange
  • LAC Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • LAC 863.7M
  • RAPP 983.9M
  • IPO Year
  • LAC N/A
  • RAPP 2024
  • Fundamental
  • Price
  • LAC $3.97
  • RAPP $23.09
  • Analyst Decision
  • LAC Hold
  • RAPP Strong Buy
  • Analyst Count
  • LAC 8
  • RAPP 4
  • Target Price
  • LAC $5.06
  • RAPP $37.33
  • AVG Volume (30 Days)
  • LAC 11.9M
  • RAPP 80.1K
  • Earning Date
  • LAC 11-07-2024
  • RAPP 11-07-2024
  • Dividend Yield
  • LAC N/A
  • RAPP N/A
  • EPS Growth
  • LAC N/A
  • RAPP N/A
  • EPS
  • LAC N/A
  • RAPP N/A
  • Revenue
  • LAC N/A
  • RAPP N/A
  • Revenue This Year
  • LAC N/A
  • RAPP N/A
  • Revenue Next Year
  • LAC N/A
  • RAPP N/A
  • P/E Ratio
  • LAC N/A
  • RAPP N/A
  • Revenue Growth
  • LAC N/A
  • RAPP N/A
  • 52 Week Low
  • LAC $2.02
  • RAPP $16.55
  • 52 Week High
  • LAC $7.71
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • LAC 55.64
  • RAPP N/A
  • Support Level
  • LAC $3.56
  • RAPP N/A
  • Resistance Level
  • LAC $3.81
  • RAPP N/A
  • Average True Range (ATR)
  • LAC 0.31
  • RAPP 0.00
  • MACD
  • LAC -0.07
  • RAPP 0.00
  • Stochastic Oscillator
  • LAC 43.62
  • RAPP 0.00

About LAC Lithium Americas Corp.

Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: